Winnipeg Plasma Deaths: Health Canada Investigates | Manitoba

Canadian health officials are investigating the deaths of two people who donated plasma at for-profit clinics in Winnipeg, Manitoba, raising concerns about the safety of plasma donation and prompting a review of protocols. The investigations come amid a broader scrutiny of the rapidly expanding, and largely private, plasma collection industry in Canada.

Plasma Donation: A Growing Industry, Emerging Risks

The recent deaths, first reported by the CBC and the New York Times, have prompted Health Canada to examine the circumstances surrounding the incidents. According to Health Canada, a third death occurred in Manitoba, bringing the total number of deaths linked to plasma donation in Canada over the last decade to four. CBC News reported that one of the individuals who died was 22-year-old Rodiyat Alabede, who passed away on October 25th after a donation at a Grifols Plasma Donation Centre. Another death occurred in January 2026 at a different Grifols location in Winnipeg. Details surrounding the third Manitoba death, and the fourth death elsewhere in Canada, have not yet been publicly disclosed.

Plasma donation, unlike whole blood donation, involves extracting plasma – the liquid portion of blood – and returning red blood cells to the donor. Plasma is a critical component in the manufacturing of therapies for rare and chronic diseases, including immune deficiencies and bleeding disorders. The demand for plasma-derived therapies is increasing globally, fueling the growth of the plasma collection industry. In Canada, this growth has largely been driven by private, for-profit companies like Grifols, which offer donors financial compensation for their time and plasma.

What is Plasma and Why is it Needed?

Plasma is approximately 92% water, but it also contains vital proteins, salts, and antibodies. These components are essential for blood clotting, fighting infection, and maintaining overall health. Because plasma cannot be synthesized artificially, it must be collected from human donors. The resulting plasma is then fractionated – separated into its individual components – to create a range of life-saving therapies. These therapies are used to treat conditions such as hemophilia, autoimmune diseases, and burn victims. HealthDay News highlights the importance of plasma in medical treatments.

The Investigation and What We Recognize So Far

Health Canada is currently reviewing the protocols and safety measures in place at plasma collection centers across the country. The agency requires all plasma collection facilities to report any serious adverse reactions experienced by donors during or within 72 hours of donation. The recent deaths have prompted questions about the adequacy of these reporting requirements and the oversight of the industry.

Whereas the exact causes of death are still under investigation, the incidents have raised concerns about potential risks associated with plasma donation, including dehydration, electrolyte imbalances, and, in rare cases, more serious cardiovascular events. It’s important to note that correlation does not equal causation. the investigations are focused on determining whether the plasma donations directly contributed to the deaths, or if other underlying health conditions were a factor. The CBC investigation noted that little is known about the second death in Winnipeg beyond the fact that it occurred in January after a donation at a Grifols facility.

Who is at Risk?

The individuals who died were relatively young – 22 and an unspecified age – suggesting that even healthy individuals may be vulnerable to adverse reactions during plasma donation. But, that serious complications from plasma donation are rare. Health Canada has not released information about any pre-existing conditions the donors may have had, making it difficult to assess whether certain populations are at higher risk. The current investigations are focused on identifying any common factors among the cases and determining whether any specific protocols or procedures need to be modified to enhance donor safety.

Donor Screening and Eligibility

Plasma donation centers typically have strict screening processes in place to ensure donor eligibility. These screenings include medical questionnaires, physical examinations, and blood tests to assess overall health and identify any potential risk factors. Donors are generally required to meet specific criteria related to age, weight, and medical history. However, the effectiveness of these screening processes in preventing adverse events is now under scrutiny.

What Comes Next: Enhanced Oversight and Protocol Review

Health Canada has stated that This proves taking the recent deaths “very seriously” and is committed to ensuring the safety of plasma donors. The agency is conducting a thorough review of plasma collection practices and will consider implementing additional safety measures as needed. This may include strengthening donor screening protocols, enhancing monitoring during and after donation, and improving adverse event reporting requirements.

The investigations are also likely to lead to increased public awareness of the potential risks associated with plasma donation. Individuals considering donating plasma should carefully review the eligibility criteria and potential risks, and discuss any concerns with a healthcare professional. It is also important to choose a reputable plasma collection center that adheres to strict safety standards.

The Canadian Health Food Association (CHFA) and other health advocacy groups are likely to weigh in on the findings of the investigation and advocate for policies that prioritize donor safety. The outcome of these investigations could have significant implications for the future of the plasma collection industry in Canada, potentially leading to stricter regulations and increased oversight.